1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Hyposmia: new trials by email Literature Review of Hyposmia trials Research Report on Hyposmia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia CYR-064 - Hyposmia, Anosmia | Phase 1 | Withdrawn | University of Nebraska | 2025-04-01 | 2025-03-13 | |
| Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Stellate Ganglion Block - Anosmia, Hyposmia | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 20 | 2022-09-01 | 2026-02-12 |
Anosmia (2) · COVID-19 (1) · Olfaction Disorders (1) · Parkinson Disease (1)
Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Sensation Disorders (2) · Signs and Symptoms (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Movement Disorders (1) · Neurodegenerative Diseases (1) · Nidovirales Infections (1)
Mepivacaine (1)
University of Nebraska (1) · Washington University School of Medicine (1)
United States (1)
Mara Seier, MD (1)